TrialMedicine2015

Competing Risk Analysis for Evaluation of Dalteparin Versus Unfractionated Heparin for Venous Thromboembolism in Medical-Surgical Critically Ill Patients.

Guowei Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.